Novo Integrated Sciences Stock Price, News & Analysis
Company Description
Novo Integrated Sciences (OTC Link: NVOS) is a publicly traded medical care facilities company in the Engines & Turbines sector. The company has a market capitalization of $990.8K, ranking #7,072 among all listed U.S. companies by market cap.
NVOS stock has gained 933.3% over the past year. Shares last traded at $0.0031.
On a trailing twelve-month basis, Novo Integrated Sciences reported revenue of $13.3M with net income of -$16.2M and diluted earnings per share of $-0.89. The company operates at a net profit margin of -121.6%.
This page provides a comprehensive overview of NVOS stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Novo Integrated Sciences (NVOS) stock last traded at $0.0031. Over the past 12 months, the stock has gained 933.3%. At a market capitalization of $990.8K, NVOS is classified as a micro-cap stock with approximately 19.7M shares outstanding.
Latest News
Novo Integrated Sciences has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include earnings, buybacks, management, conferences. View all NVOS news →
SEC Filings
Financial Highlights
Novo Integrated Sciences generated $13.3M in revenue over the trailing twelve months, retaining a 43.2% gross margin, operating income reached -$10.1M (-75.8% operating margin), and net income was -$16.2M, reflecting a -121.6% net profit margin. Diluted earnings per share stood at $-0.89. The company generated -$5.1M in operating cash flow. With a current ratio of 0.37, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Novo Integrated Sciences (NVOS) currently stands at 92 shares, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 60.7%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Novo Integrated Sciences (NVOS) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
NVOS Company Profile & Sector Positioning
Novo Integrated Sciences (NVOS) operates in the Medical Care Facilities industry within the broader Engines & Turbines sector and is listed on the OTC Link.
Investors comparing NVOS often look at related companies in the same sector, including Clearday Inc (CLRD), Imac Hldgs Inc (BACK), Assure Hldgs (IONM), Genesis Heal (GENN), and Numinus Wellness Inc. (NUMIF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate NVOS's relative position within its industry.